INSIDERFilingvia Quantisnow
Icosavax Inc. logo

Icosavax (ICVX) director Wassil received 17,000 Stock Option (Right to Buy)

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Jim Wassil (director at Icosavax Inc., ICVX) reported that they received 17,000 Stock Option (Right to Buy) on Jun 6, 2023.

Reporting person
Wassil Jim

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 6, 2023Grant or award (A)Stock Option (Right to Buy)On 17,000 Common Stock1+17,000--17,000 direct

Holdings before and after

  • Stock Option (Right to Buy): 0 to 17,000 direct

Footnotes from the filing

  1. 1. 1/12th of the total number of shares of common stock subject to the option vest monthly following June 6, 2023, the vesting commencement date, provided if the next occurring annual meeting of the Issuer's stockholders occurs prior to the full vesting of the option, any remaining options will vest on the date of such annual meeting, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Wassil report in this ICVX Form 4?

Jim Wassil (director at Icosavax Inc., ICVX) reported that they received 17,000 Stock Option (Right to Buy) on Jun 6, 2023.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for ICVX

Earlier insider filings at ICVX

Quantisnow market dataNASDAQ
Icosavax Inc. logo
ICVX
Icosavax Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for ICVX

Follow ICVX and get a push notification the moment its next story breaks.

Full ICVX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICVX (Icosavax Inc.) and more on Quantisnow.